2018
DOI: 10.1080/03007995.2018.1476847
|View full text |Cite
|
Sign up to set email alerts
|

Use of MPH hemostatic powder for electrophysiology device implantation reduces postoperative rates of pocket hematoma and infection

Abstract: Using MPH hemostatic powder for post-procedural hemostasis was shown to result in a significant reduction in the rate of overall post-procedural complications (a composite endpoint of hematoma and infections), and a trend in reduction of the infections rates and device implantation site hematoma rates.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 31 publications
0
7
0
Order By: Relevance
“…Having ulcers larger than 1.5 cm in diameter is considered a risk factor for rebleeding, however (Jung et al., 2023). Polysaccharide‐based powders also featured by less postoperative complications and infections compared to other haemostatic powders in two studies investigating their use in abdominal and pelvic surgery as well as cardiac implantable electronic device implantation (O'Hanlan & Bassett, 2022; Reynbakh et al., 2018). Besides rebleeding, no serious side effects are reported in association with the use of SH powder (migration, foreign body reactions, compression and damage of tissues; Schmitz & Sodian, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…Having ulcers larger than 1.5 cm in diameter is considered a risk factor for rebleeding, however (Jung et al., 2023). Polysaccharide‐based powders also featured by less postoperative complications and infections compared to other haemostatic powders in two studies investigating their use in abdominal and pelvic surgery as well as cardiac implantable electronic device implantation (O'Hanlan & Bassett, 2022; Reynbakh et al., 2018). Besides rebleeding, no serious side effects are reported in association with the use of SH powder (migration, foreign body reactions, compression and damage of tissues; Schmitz & Sodian, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…Since the drainage effect of iNPWT alone was limited to the superficial layer of the sutured wound, hematoma formation and subsequent wound dehiscence was inevitable. Hematoma is one of the most important risk factors for SSI 34,35) . Therefore, we recognized the need for additional preventive measures against hematoma formation.…”
Section: Discussionmentioning
confidence: 99%
“…• Due to fast absorption (within 24 hours), Arista™ AH does not interfere with imaging 43 • It is associated with a minimal, if any inflammatory response 44 • The starch in the proprietary MPH technology does not exhibit starch crystallinity 45 • Arista™ AH powder is ready on demand to address diffuse surgical bleeding, with no preparation needed as an adjunct to conventional hemostasis 42 • Arista™ AH provides broad area coverage on rough surfaces and hard-to-reach areas when adjunctive hemostasis is required 2 • Complete hemostasis is achieved within minutes 46,47 • It is not associated with adhesion formation [48][49][50] • Safety and efficacy have been demonstrated across a variety of surgical areas, including general surgery, obstetrics/ gynecology, urology, cardiac, and orthopedic surgery 2,39,41,[51][52][53][54][55][56][57][58][59][60][61][62][63][64][65] However, it should be noted that some of this data was generated in preclinical models and may not correlate to performance in humans. Preclinical and clinical evidence supporting the use of MPH in a variety of surgical settings are detailed in the following sections.…”
Section: Advantages Of Arista Tm Ah Absorbable Hemostatic Particlesmentioning
confidence: 99%